Cargando…
P931: ISATUXIMAB IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH ULTRA-HIGH-RISK CYTOGENETICS: ICARIA-MM AND IKEMA SUBGROUP ANALYSIS
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431159/ http://dx.doi.org/10.1097/01.HS9.0000970628.27700.c7 |
| _version_ | 1785091135017844736 |
|---|---|
| author | Moreau, Philippe Perrot, Aurore Dimopoulos, Meletios A. Martin, Thomas Facon, Thierry Eduardo Capra, Marcelo Beksac, Meral Armstrong, Nicole Dubin, Franck Macé, Sandrine Risse, Marie-Laure Tekle, Christina Klippel, Zandra Richardson, Paul |
| author_facet | Moreau, Philippe Perrot, Aurore Dimopoulos, Meletios A. Martin, Thomas Facon, Thierry Eduardo Capra, Marcelo Beksac, Meral Armstrong, Nicole Dubin, Franck Macé, Sandrine Risse, Marie-Laure Tekle, Christina Klippel, Zandra Richardson, Paul |
| author_sort | Moreau, Philippe |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431159 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104311592023-08-17 P931: ISATUXIMAB IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH ULTRA-HIGH-RISK CYTOGENETICS: ICARIA-MM AND IKEMA SUBGROUP ANALYSIS Moreau, Philippe Perrot, Aurore Dimopoulos, Meletios A. Martin, Thomas Facon, Thierry Eduardo Capra, Marcelo Beksac, Meral Armstrong, Nicole Dubin, Franck Macé, Sandrine Risse, Marie-Laure Tekle, Christina Klippel, Zandra Richardson, Paul Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431159/ http://dx.doi.org/10.1097/01.HS9.0000970628.27700.c7 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Moreau, Philippe Perrot, Aurore Dimopoulos, Meletios A. Martin, Thomas Facon, Thierry Eduardo Capra, Marcelo Beksac, Meral Armstrong, Nicole Dubin, Franck Macé, Sandrine Risse, Marie-Laure Tekle, Christina Klippel, Zandra Richardson, Paul P931: ISATUXIMAB IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH ULTRA-HIGH-RISK CYTOGENETICS: ICARIA-MM AND IKEMA SUBGROUP ANALYSIS |
| title | P931: ISATUXIMAB IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH ULTRA-HIGH-RISK CYTOGENETICS: ICARIA-MM AND IKEMA SUBGROUP ANALYSIS |
| title_full | P931: ISATUXIMAB IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH ULTRA-HIGH-RISK CYTOGENETICS: ICARIA-MM AND IKEMA SUBGROUP ANALYSIS |
| title_fullStr | P931: ISATUXIMAB IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH ULTRA-HIGH-RISK CYTOGENETICS: ICARIA-MM AND IKEMA SUBGROUP ANALYSIS |
| title_full_unstemmed | P931: ISATUXIMAB IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH ULTRA-HIGH-RISK CYTOGENETICS: ICARIA-MM AND IKEMA SUBGROUP ANALYSIS |
| title_short | P931: ISATUXIMAB IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH ULTRA-HIGH-RISK CYTOGENETICS: ICARIA-MM AND IKEMA SUBGROUP ANALYSIS |
| title_sort | p931: isatuximab in relapsed multiple myeloma patients with ultra-high-risk cytogenetics: icaria-mm and ikema subgroup analysis |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431159/ http://dx.doi.org/10.1097/01.HS9.0000970628.27700.c7 |
| work_keys_str_mv | AT moreauphilippe p931isatuximabinrelapsedmultiplemyelomapatientswithultrahighriskcytogeneticsicariammandikemasubgroupanalysis AT perrotaurore p931isatuximabinrelapsedmultiplemyelomapatientswithultrahighriskcytogeneticsicariammandikemasubgroupanalysis AT dimopoulosmeletiosa p931isatuximabinrelapsedmultiplemyelomapatientswithultrahighriskcytogeneticsicariammandikemasubgroupanalysis AT martinthomas p931isatuximabinrelapsedmultiplemyelomapatientswithultrahighriskcytogeneticsicariammandikemasubgroupanalysis AT faconthierry p931isatuximabinrelapsedmultiplemyelomapatientswithultrahighriskcytogeneticsicariammandikemasubgroupanalysis AT eduardocapramarcelo p931isatuximabinrelapsedmultiplemyelomapatientswithultrahighriskcytogeneticsicariammandikemasubgroupanalysis AT beksacmeral p931isatuximabinrelapsedmultiplemyelomapatientswithultrahighriskcytogeneticsicariammandikemasubgroupanalysis AT armstrongnicole p931isatuximabinrelapsedmultiplemyelomapatientswithultrahighriskcytogeneticsicariammandikemasubgroupanalysis AT dubinfranck p931isatuximabinrelapsedmultiplemyelomapatientswithultrahighriskcytogeneticsicariammandikemasubgroupanalysis AT macesandrine p931isatuximabinrelapsedmultiplemyelomapatientswithultrahighriskcytogeneticsicariammandikemasubgroupanalysis AT rissemarielaure p931isatuximabinrelapsedmultiplemyelomapatientswithultrahighriskcytogeneticsicariammandikemasubgroupanalysis AT teklechristina p931isatuximabinrelapsedmultiplemyelomapatientswithultrahighriskcytogeneticsicariammandikemasubgroupanalysis AT klippelzandra p931isatuximabinrelapsedmultiplemyelomapatientswithultrahighriskcytogeneticsicariammandikemasubgroupanalysis AT richardsonpaul p931isatuximabinrelapsedmultiplemyelomapatientswithultrahighriskcytogeneticsicariammandikemasubgroupanalysis |